115 related articles for article (PubMed ID: 3118104)
21. Stimulation of B-chronic lymphocytic leukemia populations by recombinant interleukin-4 and other defined growth-promoting agents.
Ghaderi AA; Richardson P; Cardona C; Millsum MJ; Ling N; Gillis S; Ledbetter J; Gordon J
Leukemia; 1988 Mar; 2(3):165-70. PubMed ID: 3126369
[TBL] [Abstract][Full Text] [Related]
22. Defective interleukin-2 production and responsiveness by T cells in patients with chronic lymphocytic leukemia of B cell variety.
Ayanlar-Batuman O; Ebert E; Hauptman SP
Blood; 1986 Feb; 67(2):279-84. PubMed ID: 2935203
[TBL] [Abstract][Full Text] [Related]
23. Demonstration of high-affinity interleukin-2 receptors on B-chronic lymphocytic leukemia cells: functional and structural characterization.
Yagura H; Tamaki T; Furitsu T; Tomiyama Y; Nishiura T; Tominaga N; Katagiri S; Yonezawa T; Tarui S
Blut; 1990 Mar; 60(3):181-6. PubMed ID: 2180499
[TBL] [Abstract][Full Text] [Related]
24. Direct effect of interleukin 2 on chronic lymphocytic leukaemia B cell functions and morphology.
Malkovska V; Murphy J; Hudson L; Bevan D
Clin Exp Immunol; 1987 Jun; 68(3):677-84. PubMed ID: 3115651
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the expression of IL 2 receptors by human T and B cells: induction by the polyclonal mitogens, phorbol myristate acetate, and anti-mu antibody.
Suzuki T; Cooper MD
J Immunol; 1985 May; 134(5):3111-9. PubMed ID: 2580014
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-2 and a T cell hybridoma (MP6) derived B cell-stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells.
Carlsson M; Tötterman TH; Rosén A; Nilsson K
Leukemia; 1989 Aug; 3(8):593-601. PubMed ID: 2787454
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1.
Jelinek DF; Lipsky PE
J Immunol; 1987 Nov; 139(9):2970-6. PubMed ID: 3117883
[TBL] [Abstract][Full Text] [Related]
28. Impaired expression of cell surface receptors for B cell growth factor by chronic lymphocytic leukemia B cells.
Perri RT
Blood; 1986 Apr; 67(4):943-8. PubMed ID: 3485460
[TBL] [Abstract][Full Text] [Related]
29. Induction of IgG secretion in a human B cell clone with recombinant IL 2.
Kishi H; Inui S; Muraguchi A; Hirano T; Yamamura Y; Kishimoto T
J Immunol; 1985 May; 134(5):3104-7. PubMed ID: 3920311
[TBL] [Abstract][Full Text] [Related]
30. Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.
Weil-Hillman G; Voss SD; Fisch P; Schell K; Hank JA; Sosman JA; Sugamura K; Sondel PM
Cancer Res; 1990 May; 50(9):2683-91. PubMed ID: 1691679
[TBL] [Abstract][Full Text] [Related]
31. Expression of interleukin-2 receptor on T cell chronic lymphocytic leukemia cells and their response to interleukin-2.
Tsudo M; Uchiyama T; Umadome H; Wano Y; Hori T; Tamori S; Uchino H; Kita K; Chiba S; Mitsutani S
Blood; 1986 Feb; 67(2):316-21. PubMed ID: 3080037
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-2 receptor is functionally linked with in vitro activation of B cells isolated from non-Hodgkin's lymphomas.
Garraud O; LeGrand E; Eghbali H; Hoerni-Simon G; Hoerni B; Guillemain B
Diagn Clin Immunol; 1988; 5(6):417-20. PubMed ID: 3265363
[TBL] [Abstract][Full Text] [Related]
33. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.
Harel-Bellan A; Bertoglio J; Quillet A; Marchiol C; Wakasugi H; Mishall Z; Fradelizi D
J Immunol; 1986 Apr; 136(7):2463-9. PubMed ID: 3005412
[TBL] [Abstract][Full Text] [Related]
34. Interleukin 2 receptors are expressed by alveolar macrophages during pulmonary sarcoidosis and are inducible by lymphokine treatment of normal human lung macrophages, blood monocytes, and monocyte cell lines.
Hancock WW; Muller WA; Cotran RS
J Immunol; 1987 Jan; 138(1):185-91. PubMed ID: 3097144
[TBL] [Abstract][Full Text] [Related]
35. Immunoregulatory T-cell defects in B-cell chronic lymphocytic leukemia: cause or consequence of the disease? The contributory role of decreased availability of interleukin 2 (IL-2).
Foa R; Fierro MT; Giovarelli M; Lusso P; Benetton G; Bonferroni M; Forni G
Blood Cells; 1987; 12(2):399-412. PubMed ID: 2887225
[TBL] [Abstract][Full Text] [Related]
36. Demonstration that human B cells respond differently to interleukin 2 and B cell differentiation factor based on their stages of maturation.
Nakagawa T; Nakagawa N; Goldstein H; Volkman DJ; Fauci AS
J Immunol; 1986 Nov; 137(10):3175-82. PubMed ID: 2945860
[TBL] [Abstract][Full Text] [Related]
37. Differentiation of purified malignant B cells induced by PMA or by activated normal T cells.
van Kooten C; Rensink I; Aarden L; van Oers R
Leukemia; 1993 Oct; 7(10):1576-84. PubMed ID: 8105156
[TBL] [Abstract][Full Text] [Related]
38. IL-4 inhibits the expression of high affinity IL-2 receptors on monoclonal human B cells.
Karray S; Dautry-Varsat A; Tsudo M; Merle-Beral H; Debre P; Galanaud P
J Immunol; 1990 Aug; 145(4):1152-8. PubMed ID: 2380552
[TBL] [Abstract][Full Text] [Related]
39. The proliferative response of B cell chronic lymphocytic leukemia to interleukin 2: functional characterization of the interleukin 2 membrane receptors.
Touw I; Dorssers L; Löwenberg B
Blood; 1987 Jun; 69(6):1667-73. PubMed ID: 3107631
[TBL] [Abstract][Full Text] [Related]
40. Sequential synergistic effect of interleukin 2 and interferon-gamma on the differentiation of a Tac-antigen-positive B cell line.
Nakagawa T; Nakagawa N; Volkman DJ; Fauci AS
J Immunol; 1986 Jan; 136(1):164-8. PubMed ID: 2999242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
